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BACKGROUND: Fertility preservation (FP) is an important quality of life issue for cancer survivors of reproductive age. Despite the
existence of broad international guidelines, the delivery of oncofertility care, particularly amongst paediatric, adolescent and young adult
patients, remains a challenge for healthcare professionals (HCPs). The quality of oncofertility care is variable and the uptake and utilization
of FP remains low. Available guidelines fall short in providing adequate detail on how oncofertility models of care (MOC) allow for the
real-world application of guidelines by HCPs.
OBJECTIVE AND RATIONALE: The aim of this study was to systematically review the literature on the components of oncofertility
care as defined by patient and clinician representatives, and identify the barriers, facilitators and challenges, so as to improve the implemen-
tation of oncofertility services.
SEARCH METHODS: A systematic scoping review was conducted on oncofertility MOC literature published in English between 2007
and 2016, relating to 10 domains of care identified through consumer research: communication, oncofertility decision aids, age-appropriate
care, referral pathways, documentation, training, supportive care during treatment, reproductive care after cancer treatment, psychosocial
support and ethical practice of oncofertility care. A wide range of electronic databases (CINAHL, Embase, PsycINFO, PubMed, AEIPT,
Education Research Complete, ProQuest and VOCED) were searched in order to synthesize the evidence around delivery of oncofertility
care. Related citations and reference lists were searched. The review was undertaken following registration (International prospective regis-
ter of systematic reviews (PROSPERO) registration number CRD42017055837) and guidelines of Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA).
OUTCOMES: A total of 846 potentially relevant studies were identified after the removal of duplicates. All titles and abstracts were
screened by a single reviewer and the final 147 papers were screened by two reviewers. Ten papers on established MOC were identified
amongst the included papers. Data were extracted from each paper and quality scores were then summarized in the oncofertility MOC
summary matrix. The results identified a number of themes for improving MOC in each domain, which included: the importance of
patients receiving communication that is of a higher quality and in different formats on their fertility risk and FP options; improving provision
of oncofertility care in a timely manner; improving access to age-appropriate care; defining the role and scope of practice of all HCPs; and
improving communication between different HCPs. Different forms of decision aids were found useful for assisting patients to understand
FP options and weigh up choices.
WIDER IMPLICATIONS: This analysis identifies core components for delivery of oncofertility MOC. The provision of oncofertility ser-
vices requires planning to ensure services have safe and reliable referral pathways and that they are age-appropriate and include medical
and psychological oncofertility care into the survivorship period. In order for this to happen, collaboration needs to occur between clini-
cians, allied HCPs and executives within paediatric and adult hospitals, as well as fertility clinics across both public and private services.
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Training of both cancer and non-cancer HCPs is needed to improve the knowledge of HCPs, the quality of care provided and the confi-
dence of HCPs with these consultations.
Key words: fertility preservation / oncofertility / survivorship / models of care / late effects / systematic review / communication /
training
Introduction
Oncofertility care includes fertility preservation (FP) discussion and
management, as well as the management of sexual dysfunction, hor-
monal dysfunction, complex contraception and fertility-related psy-
chosocial support (Anazodo, Ataman-Millhouse, Jayasinghe and
Woodruff, 2018; Burns et al., 2018). The field has undergone rapid
advancements in recent years, improving effectiveness and increasing
demand for access from patients and HCPs (Anazodo et al., 2018;
Burns et al., 2018).
The ability to bear children is important to a majority of people
and procreation is a basic human instinct, so the inability to bear a
child can be devastating for most individuals. FP has been cited as
one of the top five unmet needs for adolescent cancer patients, along
with health, work/school, romantic relationships and close friends
(Klosky et al., 2015). FP raises increasingly important medical and
quality of life issues for cancer survivors. Therefore, wherever pos-
sible, oncofertility care should be an integral part of cancer care from
diagnosis through to survivorship.
Despite international evidence about the importance of, and effect-
ive ways to deliver, oncofertility care and the availability of 20 differ-
ent high-level guidelines or models of care (MOC) to steer practice
(Multi-disciplinary Working Group convened by the British Fertility
Society, 2003; Physicians, 2007; Fallat and Hutter, 2008; Pentheroudakis
et al., 2009; French Association for the Care of Oncological Support,
2011; National Comprehensive Cancer Network, 2011; von Wolff
et al., 2011; Cardoso et al., 2012; Kim et al., 2012; AYA cancer fertility
preservation guidance working group, 2013; Hoog-Labouret and Merlet,
2013; Loren et al., 2013; Martínez et al., 2013; National Institute for
Health and Care Excellence, 2013; Scottish Intercollegiate Guidelines
Network, 2013; Sudour-Bonnange et al., 2013; ‘Fertility preservation for
AYAs diagnosed with cancer: Guidance for health professionals,’ 2014;
Joshi et al., 2014; network, 2014; Roberts et al., 2015; Yasmin et al.,
2018; Practice Committee of American Society for Reproductive
Medicine, 2014), FP care is often under-implemented. Several barriers
have been found to thwart the implementation of comprehensive and
equitable FP practice. These include: (i) a lack of referral pathways and
MOC for oncofertility services and collaboration between cancer and
fertility doctors to deliver services; (ii) inequitable access based on cost;
(iii) health literacy; (iv) a lack of trained staff who can deliver these ser-
vices; and (v) no consensus about the best way to deliver information to
patients (Vadaparampil et al., 2008b; Panagiotopoulou et al., 2015).
Available guidelines fall short of providing adequate detail to inform
real-world application and lack of effective strategies to reduce or
avoid key implementation barriers. To ensure that all patients are
sufficiently empowered to make fully informed FP decisions and
receive adequate reproductive follow-up care after cancer treatment,
together with access to fertility-related psychosocial support, it is
important that an inclusive MOC be developed that reflects current
evidence and experiential knowledge across this multifaceted and
largely complex domain.
Healthcare providers who are skilled in fundamental competencies
and effective health service processes, such as reliable MOCs and refer-
ral pathways, underpin high quality oncofertility care. The findings, gar-
nered from systematically characterizing appropriate oncofertility care,
will be used as a first step in the development of an oncofertility compe-
tency framework to facilitate comprehensive education and professional
development in this field.
Aims
The aim of the current study is to systematically review the literature
on the components of oncofertility care for paediatric, adolescent
and adult cancer patients, as defined by patient and clinician repre-
sentatives, and then identify the barriers, facilitators and challenges of
these components so as to improve the implementation of oncoferti-
lity services.
Methods
As the components of oncofertility are broad and complex, and the lit-
erature includes studies with different methodologies, a systematic
scoping review was undertaken following registration (International pro-
spective register of systematic reviews (PROSPERO) registration number
CRD42017055837) and guidelines of Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA).
The preliminary stage of any review is a clear identification of the prob-
lem being investigated. A focus group consultation with 50 consumers
(patients, partners and parents) was undertaken prior to the review to
identify areas they considered were valuable or missing from their onco-
fertility care experience. Eight strategies (domains) were identified: (i)
communication; (ii) oncofertility decision aids; (iii) age-appropriate care;
(iv) referral pathways; (v) documentation; (vi) oncofertility training; (vii)
reproductive survivorship care; and (viii) fertility-related psychosocial sup-
port. The consumer-identified domains were augmented with two further
areas identified by Australian clinical researchers as being important from
a medical perspective: (i) ethical practice of oncofertility care; and (ii)
provision of medical care during FP treatment. This review considered all
studies in which at least one of the 10 identified strategies were
addressed and reported from the clinician or patient perspective. No
restrictions were made on clinician type or speciality, with all studies
reporting on an oncofertility MOC strategy included.
A comprehensive literature search strategy was devised and performed
in October 2017 (Table I) with suitable studies identified for the period
of 2007–2016 by searching of electronic databases PubMed, EMBASE,
PsycINFO and CINAHL, alongside the screening of relevant reference
lists. Education databases (AEIPT, Education Research Complete,
ProQuest and VOCED) were also searched but did not yield any relevant
papers. Oncofertility practice was defined in 2007 (Woodruff, 2007) and
since then significant investments in clinical and research practice have
resulted in the availability of increasing evidence about medical and
3Oncofertility models of care
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Table I Search terms used across electronic databases.
PubMed (627) Embase (467) CINAHL (12) PsycINFO (67)
English language, Humans, published 2007–2016
Neoplasms [MeSH] OR
cancer OR tumour/tumour OR oncology
Neoplasm [Emtree] OR cancer OR
tumour/tumour OR oncology
Neoplasms [subject] OR cancer OR
tumour/tumour OR oncology
Neoplasms OR cancer OR tumour/tumour
OR oncology
Fertility preservation [MeSH] OR
cryopreservation [MeSH] OR semen
preservation [MeSH] OR
‘fertility preservation’ OR
oncofertility OR
‘sperm banking’ OR ‘oocyte
cryopreservation’ OR ‘ovarian
cryopreservation’ OR ‘testicular
cryopreservation’
Fertility preservation [Emtree] OR
cryopreservation [Emtree] OR sperm
preservation [Emtree] OR
‘fertility preservation’ OR
oncofertility OR
‘sperm banking’ OR ‘oocyte
cryopreservation’ OR ‘ovarian
cryopreservation’ OR ‘testicular
cryopreservation’
Fertility preservation [subject] OR
cryopreservation [subject] OR semen
preservation [subject] OR
‘fertility preservation’ OR
oncofertility OR
‘sperm banking’ OR ‘oocyte
cryopreservation’ OR ‘ovarian
cryopreservation’ OR ‘testicular
cryopreservation’
‘Fertility preservation’ OR cryopreservation
OR ‘semen preservation’ OR oncofertility
OR ‘sperm banking’ OR ‘oocyte
preservation’ OR ‘ovarian preservation’ OR
testicular preservation’
Domains
Communication skills Communication [MeSH] OR
communication (76)
Interpersonal communication/ [Emtree]
OR communication (59)
Communication [subject] OR
communication (9)
Communication/ OR communication (19)
Decision aids Decision Support Techniques [MeSH] OR
‘decision aid’ (8)
‘decision aid’ (12) Decision Support Techniques [subject] OR
‘decision aid’ (1)
‘decision aid’ (1)
Provision of age-
appropriate care
‘age-appropriate care’ OR ‘provision of
care’ (2)
‘age-appropriate care’ OR ‘provision of
care’ (1)
‘age-appropriate care’ OR ‘provision of
care’ (0)
‘age-appropriate care’ OR ‘provision of
care’ (1)
Referral pathways Referral and Consultation [MeSH] OR
referral (104)
Patient referral/ [Emtree] OR referral (137) Referral and Consultation [subject] OR
referral (0)
Professional referral/ OR referral (8)
Documentation Documentation [MeSH] OR documentation
(23)
Medical documentation/ [Emtree] OR
documentation (22)
Documentation [subject] OR
documentation (0)
Documentation (0)
Training Education [MeSH] OR training (145) Training/[Emtree]
OR
Education/[Emtree] (63)
Education [subject] OR training (0) Education/OR training (10)
Supportive care ‘supportive care’ (5) ‘supportive care’ (15) ‘supportive care’ (0) ‘supportive care’ (3)
Reproductive care in
survivorship
‘reproductive care’ (5) ‘reproductive care’ (5) ‘reproductive care’ (0) ‘reproductive care’ (0)
Psychosocial support psychosocial (39) Psychosocial care/[Emtree] OR
psychosocial (14)
psychosocial (2) psychosocial (18)
Oncofertility models
of care
‘model of care’ OR program (124) ‘model of care’ OR program (114) ‘model of care’ OR program (0) ‘model of care’ OR program (3)
Ethics ethics (96) Ethics/ [Emtree] (25) Ethics (0) Ethics (4)
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psychosocial oncofertility care. Therefore, oncofertility MOC that were
developed in the first 10 years of this new sub-speciality were evaluated.
All titles and abstracts were screened and to ensure inter-rater reliability,
two reviewers reviewed the full text of the included studies to confirm
eligibility. Discrepancies between ratings of inclusion on studies were dis-
cussed between the two reviewers until a consensus was reached. As
studies were expected to be heterogeneous, a narrative synthesis was
planned.
Quality analysis and data extraction
The quality of the final studies was assessed using the Mixed Methods
Appraisal Tool (MMAT) (Pluye, Gagnon et al., 2009; Pace, Pluye et al.,
2012), a valid instrument for testing mixed method reviews and utilized
worldwide (Pace et al., 2012). Scores on the MMAT vary from 25% (one
criterion met) to 100% (all criteria met) with quality assessed according
to four criteria related to either qualitative or quantitative enquiry. Data
were extracted from each individual paper and are summarized in
Supplementary Table S1 with the MMAT score. Conventional content
analysis was used to analyse the cancer and fertility papers and draw out
the themes for reproductive concerns from each paper. These themes
were then grouped and coded accordingly to assess group differences
and trends.
Results
Study characteristics
The literature search identified 846 potentially relevant studies after the
deletion of duplicates (Fig. 1). Full text review of 261 studies was com-
pleted and 147 studies met the eligibility criteria. Of the 147 studies
included, 102 were quantitative, 40 were qualitative utilizing discourse,
content and thematic analyses, and five utilized mixed methods. All stud-
ies were of reasonable quality (50–100%) by MMAT score and were
therefore included in this review. The studies were first published
between 2007 and 2016, and were conducted across 20 countries
representing middle and high-income nations and a range of clinical dis-
ciplines. While 42 papers focussed on female patient data or
experiences, 32 were on both male and female patients and 12
were on males only. Three papers included paediatric patient
data only, although several included paediatric and adult data.
Papers reported on patients who had been recently diagnosed
(within a few weeks) through to surviving patients (several years
post diagnosis). There were 64 papers which summarized the
views of healthcare professionals (HCPs) or institutional factors.
Information from the 147 papers was examined in relation to the
10 domains and summarized below. A systematic analysis with two
coders (Table II) is presented as well as a summary of the impact,
challenges and barriers to delivering oncofertility practice and policy.
Domain 1: communication
The review identified six themes on communication: timing of FP dis-
cussion, role of HCPs in communicating about oncofertility care, type
of communication, age-appropriate communication, quality of com-
munication and communication between colleagues.
There were 28 papers providing information on the timing and ini-
tiation of FP discussion (Table II, section 1a) with significant variation
reported in timing of such discussions. In one study, as few as 9% of
patients reported receiving any information on fertility risk or FP
options (Goldfarb et al., 2016), while in another study 22% of
patients were counselled on FP before, 6% during, and 7% after can-
cer treatment (Hohmann et al., 2011). In another study, of those
counselled, 78% had FP discussions before treatment (Chin et al.,
2016). Cancer survivors and nurses believe the clinician should initi-
ate the conversation about FP (Gorman et al., 2012; Murray et al.,
2016), however, between 23 and 50% of discussions were initiated
by the patient or a family member or friend (Rabah et al., 2010;
Scanlon et al., 2012; Yee et al., 2012b; Chin et al., 2016; Yee, 2016).
A study of 115 paediatric oncology nurses showed that low rates of
fertility discussion was associated with them not wanting to upset
patients and families, not wanting to give out erotic material to male
minors and not having appropriate resources (Vadaparampil et al.,
2007) (Table II, section 1a).
In a Delphi study of HCPs, all agreed that patients should be given
clear and objective information about FP shortly after diagnosis and
this should be followed up with more detailed information from a fer-
tility expert later on (Garvelink et al., 2012). Patients, irrespective of
age and sex, indicated their preference to receive fertility information
around the time of diagnosis (Crawshaw et al., 2009; Lee et al.,
2011a). Parents have also indicated that they would have liked more
information about fertility at the time of their child’s diagnosis (Stein
et al., 2014; Ellis et al., 2016).
There were 21 papers discussed the role of staff in communicating
about FP (Table II, section 1b). The majority of cancer physicians
believe it is their role to raise questions of fertility with patients and,
to a lesser extent, FP options (Duffy et al., 2012; Overbeek et al.,
2014). Despite this, one study found that 40% of clinicians thought
that patients should bring up the topic (Ghorbani et al., 2011).
Clinicians who believe discussing FP is their responsibility are twice as
likely to discuss it (Takeuchi et al., 2017). Clinicians who attend FP
Records after duplicates removed
(n = 846) 
Records screened 
(n = 846) 
Records excluded
(n = 585)
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Figure 1 Flowchart of inclusion and exclusion process.
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Table II Summary table showing illustrative examples of oncofertility model of care strategies.
Domain Illustrative examples of relevant findings
1. Communication skills a. Timing of FP discussion
40% of clinicians thought patients should bring up the topic of FP (Ghorbani et al., 2011).
Many of a group of oncology nurses surveyed felt that oncologists should be responsible for initiating FP discussions (Murray
et al., 2016).
Among adult survivors of childhood cancer, 22% were counselled on FP before, 6% during and 7% after cancer treatment
(Hohmann et al., 2011).
b. Role of staff
In a Delphi study, experts agreed that patients should be given clear and objective information about FP shortly after
diagnosis and more detailed information from a fertility expert later on (Garvelink et al., 2012).
Half of the oncology nurses reported discussing FP with patients (King et al., 2008b).
c. Type of communication
A survey of oncologists found that 97% used only verbal communication (Yee et al., 2012c).
Brochures were found useful by 96% of male and 93% of female young adult patients (Tam et al., 2016).
d. Age-appropriate nature of communication
Covered in 3a.
e. Quality of communication
Covered in 3e.
f. Communication between staff
HCPs had difficulties communicating between professionals of the same speciality (Shimizu et al., 2015) or different
specialities (Shimizu et al., 2015; Abe et al., 2016). This was echoed from the patient perspective, that clinicians should
communicate more effectively with each other (Garvelink et al., 2013).
2. Oncofertility decision aids Patients who received a decision aid showed higher knowledge and lower regret at 12 months and were more likely to
discuss FP with their oncologist and to be referred to a fertility specialist (Peate et al., 2012).
Parents and healthcare providers had concerns about content and readability of decision aids for younger patients (aged
12–21) (Murphy et al., 2012).
3. Provision of care a. Age-appropriate care
Young adult cancer patients showed high ratings of importance for information on treatment effects on fertility, FP, treating
infertility and other parenting options (Gupta et al., 2013).
Adolescent patients (12–17 years) showed eagerness to receive information about their fertility (Stinson et al., 2015).
Both young patients and their parents felt that FP services should be age-appropriate and accessible (Stinson et al., 2015).
Adult cancer survivors suggested that information should be tailored to the patient’s age (Corney and Swinglehurst, 2014).
Only 27% of female child and AYA cancer patients reported receiving enough information on FP options (Kim et al., 2016).
b. What patients want from their care
Patients want detailed, verbal and written information on options, risks, benefits, side effects and success rates of FP (Wilkes
et al., 2010; Hershberger et al., 2013; Bastings et al., 2014a; Richter et al., 2016).
Adolescent male patients felt less stressed when staff were informal, friendly and not embarrassed, and when they spoke
clearly and directly to them (Crawshaw et al., 2008).
c. Who should be involved in consultations
Patients should be involved in fertility discussions, from 7 years of age (Wyns et al., 2015).
Clinicians treating adolescent patients wanted to provide care to adolescents without the parents present (Bashore, 2007; de
Vries et al., 2009).
When male survivors were asked their preference for the initial FP conversation, 56% would have liked their parent to be
present and 44% would have preferred their parent not to be present (Ginsberg et al., 2008).
d. Clinician comfort and scope of practice
60% of clinicians rarely or never gave any FP educational materials to patients (Quinn et al., 2012).
Clinicians reported low levels of discomfort with discussions about infertility and FP for paediatric and adolescent patients
(Fuchs et al., 2016).
e. Quality of verbal and written information
73% of female survivors of paediatric and AYA cancers did not feel they had received sufficient information on FP options at
diagnosis from their cancer team (Kim et al., 2016).
Young male patients reported that receiving fertility information was a straightforward process and they felt satisfied with
having a choice about FP (Crawshaw et al., 2009).
Two-thirds of patients reported satisfaction with the quality and length of fertility discussions (Scanlon et al., 2012).
f. Institution factors
In a US study, only four out of 30 centres (13%) had a policy on provision of FP information (Clayman et al., 2013).
75% of clinicians indicated a need for FP guidelines in their institution (Vadaparampil et al., 2008a).
4. Referral pathways
between cancer and fertility
doctors
a. Rates of referral
Paediatric oncologists reported a high referral rate for older boys (83% of those at high/medium risk of infertility), but not
for girls (1%) or younger boys (39%) (Anderson et al., 2008).
Referrals to a reproductive specialist occurred in 28% of adult female breast cancer patients (Vu et al., 2017).
Continued
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Table II Continued
Domain Illustrative examples of relevant findings
Oncologists report higher referral rates for adult male patients compared with female patients (Arafa and Rabah, 2011; Yee
et al., 2012c).
One study found that referrals were most commonly from academic centres (64%) (Lee et al., 2011a).
b. Processes for referral
In a study of 28 centres, 18% had a referral protocol for FP in place (Warner et al., 2016).
In institutions with an established referral pathway including standard referral forms, and sometimes a patient navigator to
assist with the process, referrals are more streamlined (Johnson and Kroon, 2013).
c. Factors affecting referral
Referrals are increased when alliances are formed between cancer and fertility specialists (Dyer and Quinn, 2016).
In institutions with an established referral pathway including IT system prompts and referral forms, and sometimes a patient
navigator to assist with the process, referrals are more streamlined (Ogle et al., 2008; Reinecke et al., 2012; Johnson and
Kroon, 2013).
Patients are more likely to be referred when they have a decision aid (Peate et al., 2012) or received other additional
information about FP, such as on risks and options (Kelvin et al., 2016).
Low rates of discussion and referral are associated with institutional factors such as difficulties finding facilities or specialists to
refer patients to (Goodwin et al., 2007; Yee et al., 2012c; Dyer and Quinn, 2016; Mahajan et al., 2016), lack of FP
information and problems integrating FP with routine cancer care (Preaubert et al., 2016).
Distance to specialist had no impact on whether patients were referred (Lee et al., 2011a; Goodman et al., 2012).
5. Documentation of
oncofertility discussions,
decisions and procedures
a. Extent of documentation
Low levels of oncofertility documentation are seen amongst both haematologists (38%) and oncologists (26%) even when
processes were in place within their institution for recording the discussion of fertility issues with patients (Gilbert et al.,
2010).
Around three-quarters of breast cancer patients had documented FP discussions prior to treatment (Srikanthan et al., 2016).
b. Extent of documentation by age
Of patients aged 18–45 years, those aged 18–30 years were significantly more likely to have documentation of infertility risk
discussion, FP options and referral (Quinn et al. 2015).
c. Factors affecting documentation
Patient records regarding FP before and after oncofertility program formalization showed that, of 18–40 year olds, 23% were
offered FP before and 43% were offered FP after the program was developed (Sheth et al., 2012).
Access to a fertility navigator or coordinator of FP lead to increased documentation (Gilbert et al., 2010; Salsman et al.,
2016).
6. Training of cancer and
fertility healthcare
professionals to deliver
oncofertility care
a. Level of training and knowledge of cancer clinicians
Of 54 oncologists, the majority had received little or no training in FP and this affected their ability to discuss the topic with
patients (Quinn et al., 2009b).
Clinicians with favourable attitudes towards FP (Quinn et al., 2009a; Shimizu et al., 2013), more knowledge (Quinn et al.,
2009a; Shimizu et al., 2013), and who have these discussions more frequently (Forman et al., 2009; Louwé et al., 2018) have
improved rates of referral for FP.
b. Level of training and knowledge of non-cancer clinicians
Gynaecologists had good knowledge and felt confident providing advice and referral for FP, before, during and after cancer
treatment (Duncan et al., 2011).
A survey found a lack of training of haematologists about FP (Gilbert et al., 2010).
c. Level of training and knowledge of allied health professionals
Social workers have been shown to have limited knowledge of FP resources and clinics (King et al., 2008b).
21% of allied health professionals had undertaken training relating to fertility in cancer patients, compared with 37% of
doctors and 31% of nurses (Ussher et al., 2016).
d. Types of education and tools
The ENRICH online training program showed positive outcomes, including that most trainees improved their knowledge and
initiated change to facilitate FP within their institution (Vadaparampil et al., 2016).
In a successful FP program, training for medical or fertility clinicians was both formal and informal, and ongoing (Ogle et al.,
2008).
Types of education include Grand Rounds (Quinn et al., 2011) and internal education sessions (Forman et al., 2009).
e. Clinician comfort and scope of practice
Covered in 3d.
7. Medical supportive care during fertility preservation: No relevant literature found.
8. Reproductive care in
survivorship
a. Patients’ fertility status following cancer treatment
Many cancer survivors were found to have incorrect beliefs about the extent of their fertility problems, which did not reflect
the information received (Crawshaw and Sloper, 2010).
b. Fertility investigations following cancer treatment
15% of female survivors of childhood or AYA cancer had a fertility consultation following cancer treatment (Kim et al., 2016).
Continued
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education sessions are more likely to consider FP routinely in treat-
ment planning (Forman et al., 2009).
Resident doctors were found very likely to discuss FP with female
patients (Yu et al., 2015), as were nurses and general practitioners
(Pacey et al., 2013), and over half of paediatric endocrinologists sta-
ted that they held these conversations (54%) (Miyoshi et al., 2016).
Similarly, half of a group of oncology nurses reported discussing FP
with patients, and similarly to doctors, reported knowledge and com-
fort level as barriers to discussions (King et al., 2008a). The import-
ance of nurses (Vadaparampil et al., 2007; Nagel et al., 2009),
gynaecologists (Duncan et al., 2011) and social workers (Ogle et al.,
2008), being included in FP discussions have all been emphasized
across different studies. One study described the benefits of social
workers to facilitate the discussion once it has been initiated, as their
skills lie in providing emotional support and assisting patients to find
resources (King et al., 2008b).
There were 17 papers which included themes on the type of com-
munication (see Table II, section 1c). In one study, clinicians reported
that patients and parents are usually given printed resources, then
directed to certain websites for further information (Fuchs et al.,
2016). While referral to written and online resources occurs (Reinecke
et al., 2012; Pacey et al., 2013; Besharati et al., 2016), other studies indi-
cate that clinicians are not consistent in providing comprehensive
information (Buske et al., 2016) and clinicians generally only use verbal
communication (Gilbert et al., 2010; Yee et al., 2012c). In fact, one study
found that 60% of clinicians rarely or never gave any FP educational
materials to patients (Quinn et al., 2012). From the patient perspective,
one study of male patients found that 58% later recalled having seen
written information about sperm banking (Pacey et al., 2013), while a
second study of 20 female patients showed that none received any FP
information prior to treatment (Karaöz et al., 2010).
There was an overlap in research findings about communication
and provision of care and these results are discussed under domain 3
(Table II, sections 1d and 3a).
There were 27 papers including themes on the quality of both ver-
bal and written information (Table II, sections 1e and 3e) and these
showed wide variation in the quality of oncofertility discussions and
verbal information. The first FP consultation is improved if written
materials are given (Dahhan et al., 2015). In one study, around two-
thirds of patients reported satisfaction with the quality and length of
fertility discussions (Scanlon et al., 2012) and other studies have
shown patients to be generally satisfied with the information pre-
sented (Wilkes et al., 2010; Hill et al., 2012; Garvelink et al., 2013;
Kelvin et al., 2016).
Many patients, parents and partners reported frustration that infor-
mation given was incomplete or misleading (Gorman et al., 2012;
.............................................................................................................................................................................................
Table II Continued
Domain Illustrative examples of relevant findings
Males were less likely to attend for fertility follow-up if they had negative experiences with the sperm banking process (Pacey
et al., 2012).
c. Survivorship Information needs
Both male and female patients want individual information about their fertility post cancer (Armuand et al., 2015).
Many survivors have incorrect beliefs about the extent of their fertility problems (Crawshaw and Sloper, 2010).
See also: 1. Communication skills and 3. Provision of care.
d. Survivorship emotional needs and views about care
Female patients reported frustration with the quality of care and lack of reproductive continuity of care amongst different
clinicians in survivorship, and not getting a ‘big picture’ view of their fertility (Gorman et al., 2012).
9. Fertility-related
psychosocial support
a. Negative emotions
The threat of temporary or permanent infertility was associated with psychological distress, such as depression and anxiety,
in both males and females (Lawson et al., 2015; Ellis et al., 2016)
Cancer patients experience negative emotions when they lack fertility information and support (Perz et al., 2014).
Sufficient information on FP options leads to less distress, fear and decision regret (Hohmann et al., 2011; Letourneau et al.,
2012; Peate et al., 2012; Bastings et al., 2014a).
b. Psychosocial support
Participants felt emotional support was important at all stages of treatment and recovery (Corney and Swinglehurst, 2014).
Counselling is useful at many time points due to the complexity of FP decision making (Gardino et al., 2010).
With appropriate support, patients experience less distress and decision regret, and feel more positive about the future
(Letourneau et al., 2012; Benedict et al., 2015; Lawson et al., 2015).
Who provides support—see 9c.
c. Role of professionals, family and friends
Cancer survivors reported it helpful to discuss oncofertility issues with spouses, friends and family who could provide
emotional support and assist with decision-making (Kim et al., 2013).
Patients felt oncologists and gynaecologists were most useful (Tschudin et al., 2010).
The presence of a psychologist can help improve communication between doctor and patient (Razzano et al., 2014).
Patients have stated that nurses are helpful with discussing options and making decisions (Kelvin et al., 2016).
d. Seeking support and information
Young adult patients want written or web-based information about FP (Wilkes et al., 2010).
Young patients raised the need for support from peers of around the same age (Stinson et al., 2015).
See also: 1. Communication skills and 3. Provision of care.
10: Ethical practice of oncofertility care: No relevant literature found.
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Corney and Swinglehurst, 2014; Wright et al., 2014; Banerjee and
Tsiapali, 2016; Ellis et al., 2016), that information was presented too
quickly (Garvelink et al., 2013) or that there was a lack of written
materials (Hill et al., 2012). Different studies of female patients have
shown that 73% did not receive sufficient information (Kim et al.,
2016) and 54% sought further information on their own (Scanlon
et al., 2012). Male patients have been found to be more satisfied with
the fertility discussion than female patients in some instances
(Crawshaw et al., 2009; Yeomanson et al., 2013).
Several factors had a negative impact on the quality of communica-
tion, such as communication being too fast or too late or there being
an overload of information (Garvelink et al., 2013). Several papers
showed that patients felt ill-informed (Gorman et al., 2012; Niemasik
et al., 2012; Wright et al., 2014; Ellis et al., 2016), had unanswered
questions (Corney and Swinglehurst, 2014), or did not have the risks
explained sufficiently (Niemasik et al., 2012; Banerjee and Tsiapali,
2016; Dyer and Quinn, 2016). Even when the discussion had taken
place, not all patients could recall it later (Hohmann et al., 2011;
Shnorhavorian et al., 2015).
Three papers described difficulties experienced by HCPs in communi-
cation with professionals of the same speciality (Shimizu et al., 2015) or
different specialities (Shimizu et al., 2015; Abe et al., 2016). This was
echoed by the patient perspective that clinicians should communicate
more effectively with each other (Garvelink et al., 2013).
Domain 2: oncofertility decision aids
Nine studies included themes on decision aids (Table II, section 2)
that provided assistance to understand FP options and to weigh up
the advantages and disadvantages. These took the form of decision
trees (Gardino et al., 2010), web-based or electronic educational
tools (Huyghe et al., 2009; Merrick et al., 2012; Garvelink et al.,
2013) or brochures/booklets (Devin Peate et al., 2011; Murphy
et al., 2012; Peate et al., 2012; Tam et al., 2016).
Patients, parents, partners and HCPs have reported high levels of
usefulness or satisfaction with the material (Nagel and Neal, 2008;
Peate et al., 2011; Tam et al., 2016) and found that decision aids
were clear and understandable (Garvelink et al., 2013) and that use
resulted in less FP decisional conflict (Huyghe et al., 2009; Peate
et al., 2012). In a non-randomized trial, patients aged 18–40 years
who received a decision aid also showed trends towards having high-
er knowledge and lower regret at 12 months and being more likely
to discuss FP with their oncologist (98 vs 93% who did not receive a
decision aid) and to be referred to a fertility specialist (62 vs 56% of
those without decision aids), but the perceived differences did not
reach statistical significance (Peate et al., 2012).
Patients wanted information to take to a fertility consultation
(Hershberger et al., 2013), preferred to receive both written and ver-
bal information (Tam et al., 2016) and desired information personalized
to their specific situation. The information patients suggested should be
included in a decision aid, and which would be useful to the decision-
making process, concerned medical procedures, risks, benefits, success
rates and costs (Hershberger et al., 2013). Gardino et al. (2010) demon-
strated the importance of counselling at several points in the decision-
making process and by several different care providers.
Despite this, patients, parents and healthcare providers held con-
cerns about the content and readability, and parents felt there was too
much medical terminology and too much information in general
(Murphy et al., 2012). Some patients found the information upsetting
(Peate et al., 2011). An assessment of internet resources about sperm
banking showed the reading age of all material to be ‘considerable’,
while the topics presented and their quality varied (Merrick et al., 2012).
Domain 3: provision of care, including
age-appropriate care
The review revealed six themes on provision of care: age-appropriate
care, what patients want from their care, who should be involved in
consultations, clinician comfort and scope of practice, quality of ver-
bal and written information and institutional factors. No papers dis-
cussed the best methods of delivery or digital platforms.
There were 23 papers which discussed age-appropriate care
(Table II, section 3a). A study of adolescent young adult (AYA)
patients showed high ratings of importance for information on treat-
ment effects on fertility risk, FP and other parenting options (Gupta
et al., 2013). Only one centre in a study of 15 had an adolescent-
specific brochure (Chong et al., 2010) despite AYA patients (12–17
years) being eager to receive information about their fertility (Stinson
et al., 2015) and wanting detailed, verbal and written information on
options, risks, benefits, side effects and success rates of FP (Wilkes
et al., 2010; Hershberger et al., 2013; Bastings et al., 2014a; Richter
et al., 2016), as well as printed information on specific fertility clinics
and financial resources (Tam et al., 2016).
Successful paediatric programs that feature multi-disciplinary teams
and streamlined processes for delivery of care (Johnson and Kroon,
2013; Blough et al., 2014) have been developed. The proportion of chil-
dren for whom a FP discussion occurs is unclear; however, one study
reported that 63% of oncologists routinely discussed FP with parents of
pre-pubertal male patients (Rabah et al., 2010). It has been recom-
mended that children should be involved in fertility discussions, from 7
years of age (Wyns et al., 2015) and this requires having HCPs with
expertise in caring for patients of all ages and good support systems.
There were 21 papers discussing patient preferences concerning
provision of care (Table II, section 3b). Survivors have suggested that
information should be tailored to the patient’s age (Corney and
Swinglehurst, 2014) and particular life stage, relationships and fears
(Wilkes et al., 2010) and personal story (Murphy et al., 2014). It is
important that patients feel respected and listened to (Kirkman et al.,
2013). Adult patients wanted information about different parenthood
options and assisted reproductive technology (Corney and
Swinglehurst, 2014; Richter et al., 2016). Young patients wanted
more age-appropriate content and a lower reading level or felt they
had been given too much information (Murphy et al., 2012; Fuchs
et al., 2016). Adolescent male patients felt less stressed when staff
were informal, friendly and not embarrassed, and when they spoke
clearly and directly to them (Crawshaw et al., 2008). While it may
not be practicable to prepare different information for each different
patient group, it has been suggested that basic facts could be included
along with information about further resources and contacts (Lee
et al., 2011a). In one study 43–62% of female patients reported
unmet information needs across a variety of FP topics (Benedict
et al., 2016).
In addition, males have been found to receive information about
the impact of treatment on fertility and on FP options more often
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than females (Anderson et al., 2008; Mancini et al., 2008; Armuand
et al., 2012, 2015; Barbour et al., 2013). Of females, those with no
children have been more likely to receive fertility information
(Goldfarb et al., 2016). Receiving this information gives hope and
can improve quality of life (Letourneau et al., 2012; Goldfarb et al.,
2016).
There were 14 papers discussing the types of HCPs who should
be involved in oncofertility consultations (Table II, section 3c) and 18
papers discussing comfort and scope of practice of HCPs (Table II,
section 3d). Clinicians have reported conflicting information about
the levels of comfort with FP discussions; low levels of discomfort
with discussions about infertility and FP for paediatric and adolescent
patients are reported (Vadaparampil et al., 2008b; Fuchs et al., 2016),
although clinicians can find these consultations difficult, especially if
they are used to directing the discussion through parents rather than
communicating directly with young patients (Vadaparampil et al.,
2008b). Two studies reported a preference amongst clinicians treat-
ing AYA patients to discuss provision of care without the parents
being present (Bashore, 2007; de Vries et al., 2009). Private discus-
sions have not always been possible to provide but have been pro-
posed as a means of reducing embarrassment and helping the patient
to feel more comfortable in asking questions (Bashore, 2007). Some
parents wished to have control over the content of FP discussions in
order to protect their child (de Vries et al., 2009) and some felt that
fertility information put their child under strain (Stinson et al., 2015).
In a study of paediatric endocrinologists in Japan, 13% said the
explanation of FP was only given to guardians and older adolescents
(Miyoshi et al., 2016). No cultural differences in the expectations of
clinicians or patients were noted.
Clinicians have also reported negative feelings about provision of
FP care, including feeling unprepared (Nagel and Neal, 2008), being
embarrassed (Quinn et al., 2009a), lacking confidence (Peddie et al.,
2012) and feeling uncomfortable (Quinn et al., 2009b). In one study,
43% of oncologists considered communication about FP to be difficult
and 25% considered it a burden (Buske et al., 2016), and in another,
oncologists felt that their explanations to patients about fertility were
not sufficient (Abe et al., 2016). Clinicians felt that conversations with
younger patients were awkward because of parental presence
(Quinn et al., 2009a) and it was not always possible to maintain priv-
acy (Bashore, 2007).
The papers that explored patients’ perspectives identified that
these consultations can make AYA patients feel anxious or embar-
rassed (Wyns et al., 2015) and survivors have reported that clinicians
can seem uncomfortable or dismissive (Chapple et al., 2007; Gorman
et al., 2012). When male survivors were asked their preferences,
56% would have liked their parent to be present, with the remaining
44% preferring their parent not to be present during the initial con-
versation about FP (Ginsberg et al., 2008). Patients with partners
reported that they would like their partner to be present for FP dis-
cussions (Richter et al., 2016). A study examining views on written
information found that young male patients would rather read the
brochure alone, while females would rather read it with a parent
(Murphy et al., 2014).
There were 15 papers discussed institutional issues associated with
the provision of oncofertility MOC (Table II, section 3f). The majority
of centres do not have a policy on provision of FP information. In a
US study, only four out of 30 centres did (13%) (Clayman et al.,
2013) and in another, 75% of clinicians felt guidelines were needed
for their institution (Vadaparampil et al., 2008a).
Domain 4: referral pathways between
cancer and FP services
The review identified three themes on referral pathways: rates of
referral, processes for referral and factors affecting referral.
There were 30 papers which investigated rates of referral (Table II,
section 4a). Clinician referral rates to fertility specialists varied sub-
stantially: 15% ‘routinely’ referred (Forman et al., 2009), 20% referred
(Rabah et al., 2010), 29% ‘routinely’ referred (Mahajan et al., 2016),
38% ‘actually’ referred (Abe et al., 2016), 46% ‘often’ referred
(Overbeek et al., 2014), 47% ‘routinely’ referred (Quinn et al.,
2009c), 54% ‘regularly/always’ referred (Louwé et al., 2018) and 86%
did not refer females at all (Rabah et al., 2012). However, FP referral
rates have been shown to increase over time (Dearing et al., 2014;
Sigismondi et al., 2015; Ben-Aharon et al., 2016), and this may reflect
clinical practice or uptake of FP. For example, a study of male
patients found that only 56% of those given the opportunity to bank
sperm actually did so (Pacey et al., 2013).
Oncologists report higher referral rates to fertility specialists for
adult male patients compared with female patients (Arafa and Rabah,
2011; Collins et al., 2011; Yee et al., 2012c) and paediatric centres have
higher rates for boys rather than for girls (Anderson et al., 2008) but
only 36% of oncologists felt that pre-pubertal patients should be referred
(Köhler et al., 2011). Uptake of sperm banking was found to be high
when oncologists arranged the referral process in the same way as they
arranged blood tests and scans (Eiser et al., 2011).
There were 11 papers which reviewed the process for referral,
showing that oncofertility referral pathways (Table II section 4b) are
clearly lacking. In a study of 30 cancer centres, 26% had a referral
program (Clayman et al., 2013), while in another study of 28 centres,
only 18% had a referral pathway (Warner et al., 2016). Of 306 clini-
cians in one study, 62% were aware of an established referral path-
way to a local fertility unit (King et al., 2012). In another, 30% did not
know where to refer male patients (Rabah et al., 2010). A paper
which examined referral sources showed that referrals are most
often from academic centres (64%), followed by oncologists (28%)
and patients (6%) (Lee et al., 2011b).
There were 36 papers examining different factors which affect
referral pathways (Table II, section 4c). Referrals are increased with
collaboration between cancer and fertility specialists (Dyer and
Quinn, 2016), when FP is seen as just another part of the treatment
process (Eiser et al., 2011), and by having an established referral
pathway including IT system prompts and referral forms, and some-
times a patient navigator (care navigator) to assist with referrals
(Ogle et al., 2008; Reinecke et al., 2012; Johnson and Kroon, 2013).
Referral rates have been shown to increase over time in paediatric
patients (Ben-Aharon et al., 2016) and in males (Shnorhavorian et al.,
2012) and females (Srikanthan et al., 2016). Patients are more likely
to be referred when they have a decision aid (Peate et al., 2012) or
received other additional information about FP, such as risks and
options (Kelvin et al., 2016).
One paper found referrals were more likely if the patient initiated
the discussion about FP (Campbell et al., 2016). Between two-thirds
to as many as 97% of oncologists have stated that they refer patients
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who expressed concern about their future fertility (Adams et al.,
2013; Buske et al., 2016). A study of female patients found that 52%
of those referred had requested their referral (Kim et al., 2013).
Certain healthcare provider characteristics improved referral path-
ways: having a female clinician (Quinn et al., 2009c; Shimizu et al.,
2013; Bastings et al., 2014b), clinicians having favourable attitudes
towards FP (Quinn et al., 2009a; Shimizu et al., 2013), clinicians with
more knowledge (Quinn et al., 2009a; Shimizu et al., 2013) and clini-
cians who had these discussions more frequently (Forman et al.,
2009; Louwé et al., 2018).
Certain patient characteristics were associated with high rates of
discussion and referral for FP (Table II, section 4c): male patients
(Arafa and Rabah, 2011; Yee et al., 2012c), specific types of cancer
(more common in breast cancer or lymphoma and less common in
gynaecologic, haematologic and gastrointestinal cancers) (Goodman
et al., 2012; Bastings et al., 2014a), age (generally patients 20–34
years referred most) (Goodman et al., 2012; Bastings et al., 2014a),
having no children (Goodman et al., 2012) and showing high decisio-
nal conflict (Mersereau et al., 2013).
Low rates of FP discussion and referral were associated with insti-
tutional factors such as difficulties finding facilities or specialists to
refer patients to (Goodwin et al., 2007; Yee et al., 2012c; Dyer and
Quinn, 2016; Mahajan et al., 2016), lack of FP information and pro-
blems integrating FP into routine cancer care (Preaubert et al., 2016).
Having access to fertility care navigation by HCPs (nurses, counsel-
lors, psychologists or fertility navigators) plays an important role in
coordination and referral of oncofertility care (Gilbert et al., 2010;
Scott-Trainer, 2010). The use of checklists or prompts in electronic
medical records, chemotherapy prescribing systems or paper files has
also improved referral practices (Reinecke et al., 2012; Sheth et al.,
2012; Salsman et al., 2016). Two studies found distance to the spe-
cialist had no impact on whether patients were referred (Lee et al.,
2011b; Goodman et al., 2012).
Domain 5: documentation of oncofertility
discussions, decisions and procedures
The review revealed two themes on documentation: extent of docu-
mentation and factors affecting documentation.
Ten studies covered the extent of documentation (Table II, sec-
tions 5a and 5b). One study found that 58% of patients had a docu-
mented discussion about reproductive health at the first consultation
(Wang et al., 2016). Low levels of oncofertility documentation were
seen amongst both haematologists (38%) and oncologists (26%) even
when processes were in place within their institution for recording
the discussion of fertility issues with patients (Gilbert et al., 2010). In
studies examining documentation in medical records, the notes were
more likely to be those of the cancer clinician than the nurse or
patient navigator. Documentation was better in patients with early
stage cancer (Salsman et al., 2016), in patients receiving radiation
treatment (Kumar et al., 2012), and in patients with some tumour
groups (e.g. 75% of breast cancer patients had documentation in one
study) (Srikanthan et al., 2016).
Fertility discussions were less likely to be documented for older
patients (Kumar et al., 2012; Quinn et al., 2014; Banerjee and
Tsiapali, 2016; Salsman et al., 2016) or for young patients, with only
26% of male and female AYA patient records documenting a discus-
sion about the risk of infertility, 24% documenting a discussion of FP
options, and 13% documenting a referral to a fertility specialist
(Quinn et al., 2014). Documentation was equally low for patients
who have already had children (Quinn et al., 2014; Banerjee and
Tsiapali, 2016) and for patients with no children (Quinn et al., 2014).
The level of documentation has increased over time with the
development of oncofertility programs and use of IT strategies to
improve referral pathways (Sheth et al., 2012; Salsman et al., 2016),
but on the whole, documentation levels are still low. Findings regard-
ing likelihood of having a documented discussion and patient gender
have been mixed, with one study showing female patients being
more likely (Salsman et al., 2016), one study showing male patients
being more likely (Quinn et al., 2014), and another showing no differ-
ence (Kumar et al., 2012).
Seven papers reviewed factors which improved documentation
(Table II, section 5c). Centres with oncofertility programs
(Reinecke et al., 2012; Sheth et al., 2012) have improved docu-
mentation across ages and genders (Blough et al., 2014).
However, one paper found that implementation of a FP program
was associated with higher fertility discussion and FP referrals, but
not better documentation (Srikanthan et al., 2016). Access to care
navigators coordinating care also resulted in increased documenta-
tion (Gilbert et al., 2010).
Domain 6: training of cancer and fertility
HCPs to deliver oncofertility care
The review revealed five themes on training: level of knowledge and
training in cancer clinicians, level of knowledge and training in non-
cancer clinicians, level of training in nurses and allied health profes-
sionals, types of education and clinician comfort and scope of prac-
tice. It was noted that many specific training programs would not
appear in the peer-reviewed literature if they were not evaluated.
There were 30 papers addressing cancer clinician knowledge and
training (Table II, section 6a) and 20 papers addressing knowledge
and training in non-cancer clinicians (Table II, section 6b). Almost half
of oncologists in one study were not aware of any FP options for
female patients and a study of oncologists showed that the majority
had received little or no training in FP which affected their ability to
discuss the topic with patients (Quinn et al., 2009b). Similarly, in a
large US survey of paediatric oncologists and nurses, 93% of respon-
dents reported that they had received no training on FP (Fuchs et al.,
2016). A national study in Canada, of 25 fertility clinics, found that
only 13 (52%) held training on female FP (Yee et al., 2012b).
Related to training is the clinicians’ comfort level. Patients have
perceived that clinicians were uncomfortable or dismissive (Gorman
et al., 2012). However, in some studies, high levels of comfort have
been reported by clinicians (Gilbert et al., 2010; Fuchs et al., 2016).
This may relate to how regularly clinicians have these discussions as
comfort level is viewed by clinicians as an important facilitator
(Besharati et al., 2016).
Knowledge gaps are also reported in nurses and allied health pro-
fessionals (Ussher et al., 2016) (Table II, section 6c) and in most
cases, it is the cancer clinicians raising the issue of FP with the
patient.
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Eight papers reviewed educational programs (Table II, section 6d).
HCPs want more educational materials (Nagel and Neal, 2008;
Gilbert et al., 2010; Fuchs et al., 2016) and training on FP techniques
and referral options (Quinn et al., 2007, 2009b; King et al., 2008a;
Gilbert et al., 2010; Arafa and Rabah, 2011; Köhler et al., 2011; Duffy
et al., 2012; Peddie et al., 2012; Rabah et al., 2012; Adams et al.,
2013; Overbeek et al., 2014; Campbell et al., 2016; Fuchs et al.,
2016; Louwé et al., 2018; Takeuchi et al., 2017).
An important component of successful FP programs is the educa-
tion of multi-disciplinary HCPs to provide oncofertility care (Ogle
et al., 2008; Nagel et al., 2009; Quinn et al., 2011; Reinecke et al.,
2012; Sheth et al., 2012; Shnorhavorian et al., 2012; Johnson and
Kroon, 2013).
Oncofertility communication skills training greatly improves the
knowledge and confidence of clinicians with FP discussions
(Vadaparampil et al., 2016), and online oncofertility training programs
for nurses have been developed covering fertility risks, FP options
and sexual function (Vadaparampil et al., 2016), leading to improved
knowledge and change in practice locally (Vadaparampil et al., 2013,
2016). A small pilot study demonstrated the benefits in allied health
professionals undertaking the same training (Quinn et al., 2016).
Domain 7: medical supportive care during FP
A review of the literature did not locate any data about requirements
or differences in medical supportive care for cancer patients undergo-
ing FP despite these patients being more likely to have complex med-
ical needs. These may include pancytopenia; increased risk of
bleeding or infections; mediastinal, abdominal and pelvic masses; or
medical problems which make an anaesthetic for oncofertility care
more complex or contraindicated.
Domain 8: reproductive care in survivorship
The review revealed four themes on reproductive survivorship care:
the patient’s fertility status, follow-up fertility investigations, and infor-
mation needs and emotional needs in survivors.
Ten papers highlighted a lack of understanding that survivors have
about their fertility status (Eiser et al., 2011; Wright et al., 2014), lack
of importance placed on follow-up (Eiser et al., 2011), limited fertility
follow up (Pacey et al., 2012; Kim et al., 2016) (Kim et al., 2016) and
a lack of fertility-related support in survivorship (Perz et al., 2014).
Only four studies reviewed fertility investigations following cancer
treatment (Table II, section 7b) with very low numbers of clinicians
(28%) always/often checking patients’ fertility parameters (hormonal
tests or sperm analysis) in survivorship and the other 72% rarely or
never checking or informing their patients (Preaubert et al., 2016).
Four papers looked directly at survivorship information needs
(Table II, section 7c) and this overlapped with the themes on com-
munication and provisions of care. Patients want to have individual
information about their fertility after cancer treatment (Perz et al.,
2014; Armuand et al., 2015). Many survivors had incorrect beliefs
about the extent of their fertility problems, which did not reflect the
information received (Crawshaw and Sloper, 2010), or reported frus-
tration with the quality of care and lack of reproductive continuity of
care (Gorman et al., 2012) or the lack of pregnancy planning and sup-
port (Gorman et al., 2011). This can lead to more anxiety, especially
for patients who have normal fertility parameters when finally tested.
On the other hand, some female survivors were focused on survival
and did not wish to take risks with their health by attempting to con-
ceive, particularly those who already had children (Lee et al., 2011a).
Domain 9: fertility-related psychosocial
support
The review revealed four themes on psychological support. There
were 14 papers which discussed the negative emotions patients
faced, 14 papers which explored fertility-related psychological sup-
port, five papers which focussed on the role of professional/family
support, and six papers which examined the types of psychological
support patients sought (Table II, sections 8a–d).
A patient’s fertility potential has been shown to have an impact on
their identity, well-being and life plans (Crawshaw et al., 2009). The
majority of patients felt overwhelmed by FP information and options
(Kim et al., 2016). The threat of temporary or permanent infertility
has been shown to be associated with psychological distress, such as
depression and anxiety, in both males and females (Lawson et al.,
2015; Ellis et al., 2016) and this has an effect on patients’ self-esteem,
confidence, quality of life and relationships. Loneliness was reported
by both male and female patients facing fertility loss, even those with
good support (Goossens et al., 2015). One study found that 50% of
young cancer patients (18–45 years) who wished to have children in
the future required some psychological care with regard to fertility
and parenthood (Geue et al., 2014).
Patients experience negative emotions when they lack fertility
information and support (Perz et al., 2014). Female patients wanted
more support (Mancini et al., 2008; Gorman et al., 2012; Penrose
et al., 2012) and more opportunities to ask questions and process
their feelings (Crawshaw et al., 2009). They were also more likely to
be dissatisfied with information and have higher levels of distress
(Mancini et al., 2008; Crawshaw et al., 2009; Yeomanson et al., 2013;
Armuand et al., 2015). Several studies found that the lack of time to
make decisions was associated with negative experiences of FP or
increased stress (Yee et al., 2012a; Bastings et al., 2014a) and a feeling of
being left with unanswered questions (Corney and Swinglehurst, 2014).
Females tend to experience more distress than males during decision-
making due to the lack of services for FP (Crawshaw et al., 2009). With
appropriate support, patients experience less distress, fear and decision
regret, and feel more positive about the future (Hohmann et al., 2011;
Letourneau et al., 2012; Peate et al., 2012; Bastings et al., 2014a;
Benedict et al., 2015; Lawson et al., 2015).
In a qualitative study of fertility-related experiences of female can-
cer survivors, participants felt that emotional support was important
at all stages of treatment and recovery (Corney and Swinglehurst,
2014), not just at time of diagnosis, which is the point of focus for
most studies. Counselling was found to be useful at many time
points due to the complexity of FP decision-making (Gardino et al.,
2010).
Cancer survivors have reported that they found it helpful to dis-
cuss their oncofertility choices with spouses, friends and family who
could provide emotional support and assistance with decision-making
(Kim et al., 2013). Female patients felt that, of the range of oncoferti-
lity HCPs, the most useful were oncologists and gynaecologists
(Tschudin et al., 2010). The presence of a psychologist could also be
beneficial and help to improve communication between doctor and
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patient and reduce anxiety (Razzano et al., 2014), while patients have
also stated that nurses are helpful with discussing options and making
decisions (Kelvin et al., 2016). Younger cancer survivors, aged 16–30
years, reported that both professional and parental support assisted
them to cope with receiving fertility-related information at diagnosis
(Crawshaw et al., 2009).
Our review did not find any literature discussing the benefits of
support groups or talking with other patients in similar situations.
However, one research paper did report on the benefits of fertility
discussions from data collected at a support group conference for
cancer patients aged 14 years and over (Yeomanson et al., 2013).
Domain 10: ethical practice of oncofertility
care
The review had limited literature on the ethical practice of oncoferti-
lity care, as reviews and book chapters on ethical dilemmas and legal
parameters of FP and assisted reproduction technology did not fit
within the PROSPERO inclusion criteria.
Summary of established MOC
Amongst the papers included in this review, eight described an onco-
fertility MOC (Table III) but they did not present criteria for their
measurement of success in terms of implementation or patient satis-
faction with these models. Three of the models were tailored specif-
ically to AYA patients (Ogle et al., 2008; Nagel et al., 2009;
Shnorhavorian et al., 2012; Johnson and Kroon, 2013). All of the
models included access to patient educational materials, collabora-
tions or partnerships and standard processes for referral. Five of the
models had implemented electronic notifications within their IT sys-
tems to remind clinics of the need to discuss FP. Psychological coun-
selling was not a common feature of these MOC.
Discussion
Despite a number of international recommendations and a consumer
charter for FP care (Anazodo et al., 2016), overall, this large
..............
.............................................................................................................................................................................................
Table III Established examples of oncofertility models of care and their key components.
Model Patient Pt
educational
materialA
Healthcare
Professional
EducationB
Referral
form/
Established
referral
processC
Patient
navigatorD
Collaboration/
PartnershipsE
Electronic
notification
of eligible
patientsF
Psychological
counsellingG
Sex Age
1.Colarado Oncofertility
Program (Blough et al.,
2014)
M/
F
All * – * X * * *
2.Dana-Farber Cancer
Institute (Campos et al.
2012)
M/
F
Adult * X * * * * *
3.Seattle Children’s
Hospital (Shnorhavorian
et al., 2012; Johnson and
Kroon, 2013)
M AYA * * * * * X –
4. McMaster Children’s
Hospital (Nagel et al.,
2009)
M AYA * * * X * X –
5. Children’s Hospital of
Philadelphia (Ogle et al.,
2008)
M AYA * * * Some * X X
6. H. Lee Moffit Cancer
Centre (Quinn et al.,
2011)
M/
F
Adult * * * X * * –
7. Fertile Hope Centres
of Excellence Program
(Reinecke et al., 2012)h
M/
F
All * * * some * * –
8. Northwestern
University (Oncofertility
Consortium) (Sheth et al.,
2012; Vu et al. 2017)
M/
F
All * * * * * * –
*Program has characteristic; X: Program does not have characteristic; –: Not clear whether program has characteristic.
A: Patient educational materials: brochures or audio visual material to provide information to the patient/parents. B: Clinician education: staff information or training sessions on
FP, grand rounds. C: Referral form/established process: forms/paperwork for referral, guidelines or documented process for referral. D: Patient navigator role (sometimes
referred to as patient advocate): nurse or social worker who is readily available, can provide detailed education on FP (options, location of services, costs), answer questions, assist
patient to make appointments or facilitate contact with fertility specialists (Johnson and Kroon, 2013; Scott-Trainer, 2010). E: Collaboration/partnerships: established internal
team and/or external contacts (e.g. reproductive specialists, sperm banking clinics). F: Electronic notification of eligible patients: an automatic email or other system notification set
up to remind the clinician to speak to the patient about FP. G: Psychological counselling: a psychologist available to provide emotional counselling/support for the patient.
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systematic scoping review has found that internationally the uptake
and utilization of FP remains unacceptably low and the quality of FP
care is variable, especially for younger patients of reproductive age.
This review aimed to provide an overview of current strategies for
oncofertility MOC and the strategies required to ensure that patients
not only get access to services but that these services meet the needs
of patients, partners and parents in a safe and timely manner. The
review identifies a number of strategies within each domain with
some of these overlapping across domains. Fig. 2 summarizes the
important components of oncofertility MOC.
Patients of different ages and genders and their family members
were found to have similar expectations about provisions of oncofer-
tility care. They expect to be informed about fertility risk and FP
options and they want complete, tailored information in order to
make a reproductive decision in a timely manner. Understandably,
patients do not want to find out about the reproductive risk of can-
cer treatment after treatment has started or to have to advocate for
this information themselves (Wyns et al., 2015). The emergence and
subsequent growth in the need for patient and family-centred care
will continue to drive policy and practice changes across clinical areas
including FP care (Baker, 2001). Forward looking and robust strat-
egies that ensure sustained collaborations among care and support
providers are needed to ensure that FP genuinely meets the
expectations of those impacted and does not become fragmented or
lost in the responsibility gap between primary and acute, and public
and private care systems. Agreed health system-wide international
guidelines will support acceptable practice and commitment. Such
guidelines will also create a worldwide clinical and academic network
to monitor and advance the field.
An essential component of a successful oncofertility service is a
coordinated referral pathway with a clear referral process that high-
lights the proposed treatment and risks of gonadotoxicity. These fea-
tures provide an increase in routine and timely referrals. Many cancer
centres are not fortunate to have access to FP services on the same
campus. This adds to the complexity of care for patients, especially
when they are unwell, in rural centres which require a long transfer,
or have a number of staging and toxicity investigations which also
need to be organized prior to starting treatment. IT system alerts
may help to improve FP discussions and their documentation, and
ultimately, the number of patients who will have the opportunity to
preserve fertility. Tele-health platforms can also help provide care to
patients who are in rural and remote centres as well as those patients
who are too unwell to be transferred for a fertility consultation.
Advancing scientific research on human fertility and reproductive life-
span may support more widespread availability of reproductive ser-
vices (Anderson and Telfer, 2018).
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Figure 2 Successful components of an oncofertility model of care.
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Economics was a topic that was mentioned across a range of
papers, mostly as an issue or barrier to FP. Papers did not generally
discuss finance or health insurance coverage, however, affordability is
an important factor. As FP is not universally covered by hospitals or
insurance companies, finances pose a significant barrier internationally
(Rashedi et al., 2017). The World Health Organization provides
advice and techniques to study and realize equity in healthcare in dif-
ferent contexts (Niëns, 2014) and more research is needed to ensure
that countries have equitable oncofertility practices.
Young patients and their parents believe that FP services should be
age-appropriate and accessible (Stinson et al., 2015) and older
patients feel that the service should cater for their differing needs.
Provision of oncofertility care includes the availability and access to
care that meets individual patients’ needs irrespective of age, gender
and other sociodemographic features. This includes provision of an
age-appropriate consultation space, appropriate expertise of HCPs,
written and verbal information, and age-appropriate medical and psy-
chological support. Oncofertility care in children is complex and
requires a family-centred approach with the development of specia-
lized pathways which may require consideration for the component
of care delivered in adult centres. As oncofertility care in pre-
pubertal patients is experimental research, governance should be
provided and care should be delivered within an agreed ethical
framework.
Both cancer and fertility services have experienced nurses and
allied HCPs who have an essential role in providing patient care.
Care navigators ensure that patients have information to make
informed choices and actively participate in care. They provide a vital
communication link among clinicians and other care providers,
address questions, concerns and clinical issues, and advocate for the
patient through their cancer journey into survivorship. Although our
review highlighted the benefits and success of oncofertility care navi-
gation, it also showed that HCPs often felt they lacked the skill set
and training and were unsure of their role. It is important that all clin-
ical staff, and possibly also non-clinical staff, who are involved in the
care of cancer patients are provided with oncofertility training which
includes developing oncofertility communication skills training.
Clinicians who are more knowledgeable about FP are more likely to
discuss FP with their patients and refer patients (Louwé et al., 2018).
A recent study identified a negative trend for care coordination
across health service types due to growing complexity and fragmenta-
tion of the healthcare system. It identified that a shared understand-
ing of the roles and contributions of different health professional
groups, organizations and systems is required to improve the situ-
ation. Training in system-literacy was proposed as a potential solution
through a specialized care coordination workforce (Naccarella et al.,
2016). Monitoring, linking into and leveraging off general health ser-
vice innovations may be a useful approach to ensure that FP is prop-
erly embedded in care delivery.
Internationally, there is wide variation in the FP documentation
amongst individual cancer clinicians and services (Skaczkowski et al.,
2018). This includes variation in both the documentation of an FP
consultation and discussion about FP options provided to patients,
partners and parents and variation in documentation of the oncoferti-
lity care provided. Documentation about complications and plans for
follow-up care are also poor. The documentation of consultation and
procedures is essential for communication with patients and HCPs,
provides a record for reproductive follow up and survivorship care,
and reduces potential litigation about infertility after cancer
treatment.
While papers in this review covered seventeen countries only two
papers were available from middle income countries (Iran and India)
(Ghorbani et al., 2011; Mahajan et al., 2016). These papers showed
similar findings, with oncologists and gynaecologists being familiar
with international oncofertility guidelines (67–81%), comparable with
doctors in developing countries. The barriers and challenges to onco-
fertility care for services in middle income countries were also similar
to those in high-income countries (Karaöz et al., 2010; Peate et al.,
2012) with no service availability, high costs of FP and fears of delay-
ing treatment being barriers in both countries. However, fewer clini-
cians (40–42%) discussed the gonadotoxic risk and options of FP than
the average shown in the studies from high-income countries
(0–92%). It must also be noted that limitations in oncofertility care
existed in high-income countries and there was wide variation in
practice worldwide based on the same barriers to care discussed in
this review.
It is clear that patients want to be supported during and after can-
cer treatment. Fertility-related support and care provides an oppor-
tunity to improve knowledge and patient satisfaction, and provides
hope (Logan et al., 2018). The support process should be as stream-
lined as possible and should include both practical, financial and psy-
chological support. Psychosocial support for cancer patients is
important throughout the cancer journey and this includes the FP
decision-making and procedure period as well as the survivorship
period. Advocating for oncofertility care to be covered by public
health and insurance systems will reduce the inequity that cancer
patients face.
Overall, decision aids were found to be highly useful and lead to
more discussions about FP and less decisional regret, and therefore
the use of these tools should be encouraged. Oncofertility decision
support systems aids have been developed for use in paediatric and
adolescent patients (Hand et al., 2018) and they are likely to be as
useful if they can overcome the challenge of differing reproductive
knowledge and health literacy.
Cancer patients are often left with little information or insight into
their reproductive potential which causes uncertainty and worry
(Chapple et al., 2007). Once cancer treatment has finished, there is
an opportunity for clinicians to re-summarize reproductive health
information that provided during the treatment phase and give
recommendations for reproductive health after treatment. This is
especially important for those patients who did not have FP at diag-
nosis, for those who were too young or too unwell to participate in
the conversations about FP, and those with a high chance of having
reproductive complications, including infertility.
Areas where no relevant literature was
found
Despite the absence of robust data on FP supportive care, it is
important to think about patient suitability and the medical support-
ive care needs of patients prior to recommending FP (Cakmak et al.,
2013; Shapira et al., 2015). Although this review did not identify stud-
ies looking at FP supportive care in cancer patients, clinicians need to
be aware that the risk of patients undergoing FP depends on the site
15Oncofertility models of care
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
upd/advance-article-abstract/doi/10.1093/hum
upd/dm
y038/5193422 by U
niversity of Technology, Sydney user on 18 February 2019
and size of the tumour, the side effects of ovarian stimulation on the
tumour or patients’ symptoms, the risk of bleeding and infection, and
any anaesthetic risks.
There is a distinction between general and specific ethical aspects
of oncofertility care, another domain for which no relevant studies
were found. Basic ethical principles apply to both care and the neces-
sary prior step of information for all patients at risk of loss or dimin-
ished reproductive ability when facing a cancer diagnosis and its
treatment. Such principles include: the respect of patients’ autonomy
with specific aspects concerning information and consent of a child;
the balance of beneficence and maleficence relating mostly to the
safety of the cryopreservation technique offered and the possible
danger of postponing the cancer treatment as well as the fact that
some techniques may still be considered research (Patrizio et al.,
2005); and (the societal aspect of) justice and equity which includes
access to treatment and funding by the state or insurance companies.
More specifically, the justice and equity aspects necessitate that inter-
ventions to preserve the ability to have a child should be funded pub-
licly. This funding should be considered in a structured way including
efficiency, safety and equity to avoid unjustified discrimination.
Practitioners have a moral obligation towards their patients and the
healthcare system to reduce the cost of treatment as far as reason-
ably possible (Pennings et al., 2008). Other more specific ethical
aspects include the timely renewal of consent during the storage peri-
od, posthumous treatment, donation of stored gametes or tissues to
others or for research, and the importance of interdisciplinary con-
sulting (Eshre Task Force on Ethics Law, 2004).
In addition, none of the included papers looked at the impact of
support groups which may provide practical and psychological bene-
fits to patients, parents and partners.
Strengths and limitations
The academic literature is a useful source of information on change in
an emerging key domain like FP. Comparing the literature between
the first and second time periods that this review covers, i.e.
2007–2011 and 2012–2016, shows that promising advancements in
FP are being made. The first is the considerable growth in research
in this field (102 papers in 2012–2016 compared with 45 in 2007–2011),
representing a growing number of countries (17 vs 13). Furthermore,
there has been an increase in the proportion of quantitative studies in the
2012–2016 period along with the necessary increase in the number of
study participants. It is fair to suggest that the ability to conduct
research on larger numbers of patients implies that an increasing pro-
portion of patients are now involved in FP. Secondly and encouragingly,
the review found an increase in the use of decision aids in clinical prac-
tice and an increase in health professionals receiving oncofertility edu-
cation and training. The range of HCPs, including social workers, now
involved in FP discussions also appears to be increasing. This may sig-
nify growing consideration for patient and family needs in this highly
sensitive area. Finally, HCP education and training in this field has
become more widespread and papers on specific training programs
have recently been published (Quinn et al., 2016; Vadaparampil et al.,
2016). This training has been shown to improve both the knowledge
and confidence of HCPs (Vadaparampil et al., 2016) which, in turn,
improves communication. There has been a 5-fold increase in the
number of studies emphasizing the importance of documentation of FP
in the latter half of the review time. Coverage and improvements in
rates of oncofertility documentation have been described in the last 5
years (Sheth et al., 2012; Vu et al., 2017).
This review is strengthened by the strong focus on consumer
engagement which preceded the review. Identifying strategies that
care recipients and providers perceive to be important for effective
oncofertility medical and psychological care to inform the search
strategy was considered the best approach to identifying key relevant
domains. It is also strengthened by the comprehensive nature of this
large review linking together these domains which will help in the
future implementation of oncofertility services. A diverse range of
countries were included in this review so it is likely that the results
represent diversity in clinical practices and available resources in car-
ing for patients’ oncofertility. The review also includes a wide range
of patient (childhood cancer, AYA and older adult) perspectives and
clinician (paediatric and adult cancer) perspectives from different
HCPs, although the majority of feedback was from doctors. This is
very important as multi-disciplinary oncofertility care is required for
cancer patients, from childhood to adulthood, with many different
tumour types.
A potential limitation of this research was the inclusion of only
scholarly peer-reviewed papers which met the PROSPERO criteria.
The grey literature would be expected to include information rele-
vant to several of the domains, particularly with regard to specific
oncofertility programs and training and ethical frameworks. The
review also only included papers published in English which may
result in missing some relevant papers. It is important to note that
many changes have occurred during the last 10-year period and some
of these initiatives may not have been published as yet. This review is
limited to the papers that were identified relating to the specified
domains, using MeSH terms and key words, as well as reference lists
of relevant studies. The detail summarized in each of the domains is
limited to the information available in the current publications and
may have excluded some features of successful programs or some
important strategies. Some of the domains have more relevant
papers than others, which reflects the lack of current data. A large
number of included studies are retrospective recollections by clini-
cians or patients and hence are limited in their ability to accurately
determine the exact benefits and quality of each strategy. We did not
exclude studies based on participant numbers so as not to lose the
benefit of those studies covering qualitative interviews and research
with specific groups of HCPs, though with limited data.
While the review included data from seventeen countries, only
two middle income countries are included and so this review is lim-
ited in its ability to make oncofertility recommendations for low and
middle income countries. However, it must be noted that: limitations
in oncofertility care exist in some high-income countries; there is
wide variation in practice worldwide; and the barriers identified are
the same in developing and developed countries (Rashedi et al.,
2017; Salama et al., 2018).
Paediatric, adolescent and adult cancer patients will report differ-
ent oncofertility needs, are able to access only certain FP services
dependent on pubertal status and represent a diverse range of cancer
types. As such this review is limited in its ability to draw out specific
differences required for the development of oncofertility MOC in dif-
ferent populations. Other relevant information for the development
of services such as the impact of health literacy and cultural
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components have not been considered in this review and need to be
considered in the development of services.
Conclusion
This review shows that there are many components of a successful
model of oncofertility care and many of the strategies within these
components overlap or are repeated in the referral pathway, such as
clear age-appropriate communication. The findings of this review
contribute to our knowledge about best practices in oncofertility
MOC and form the basis for the knowledge required for the devel-
opment of an oncofertility competency framework. Competencies
are used by healthcare services and HCPs to ensure that they
develop the knowledge, skills and processes to deliver services of a
high standard, and this includes suitable MOC and referral pathways
(Gonczi and Hager, 2010). Competency frameworks are based on
the hypothesis that HCPs need to have the skills to turn the available
knowledge into service development and reliable outcomes. The
availability of oncofertility competencies would allow HCPs to define
how oncofertility care should be developed in line with international
guidelines and outline clearly the specific competency for each
deliverable component of care. Oncofertility training and service
development would be instrumental in developing and maintaining
the skills and knowledge needed for oncofertility care of a high
standard.
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